Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease
分子风险标志物可确定唐氏综合征髓系白血病复发的风险,且该风险超出可测量的残留病灶范围。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025017837
Berman, Jason N; Verma, Anupam; Viola, Shelton; Alonzo, Todd A; Wang, Yi-Cheng; Brodersen, Lisa Eidenschink; Loken, Michael; Beckman, Amy; Hirsch, Betsy; Raimondi, Susana; Chisholm, Karen M; Ma, Xiaotu; Ries, Rhonda; Meshinchi, Soheil; Gamis, Alan; Schore, Reuven; Taub, Jeffrey W; Kolb, E Anders; Cooper, Todd; Hitzler, Johann